$MU · Micron Technology
Latest call · 2026-09-30
The call
Head-to-head · Claude vs the Street vs reality
| Claude | Street | Actual | |
|---|---|---|---|
| EPS | $33.50 | $31.82 | ⏳ pending |
| Revenue | $52.60B | $51.51B | — |
| Direction (1d) | 🟢 UP |
🟢 UP
30B · 4H · 0S
|
— |
| 1d move | +3.0% | — | — |
| 3d move | +5.0% | — | — |
Thesis
Micron reports Q4 FY26 into a partially de-risked setup — shares -15% from the $1,255 ATH, RSI 59, short float 2.45%, forward P/E 6.66x — that materially blunts the priced-to-perfection fade risk baked into the AI-infra super-cycle names. EPS trajectory has been parabolic ($3.03 → $25.11 across the fiscal year on HBM/DRAM ASP), and my $33.50 estimate sits +5.3% above the $31.82 consensus, tracking the +20% beat cadence of the prior two quarters. The Q1 FY27 guide is the fulcrum, not the headline.
What would flip it
A Q1 FY27 EPS guide anchored below the fwd-P/E-implied whisper of ~$40 — or any ASP-moderation qualifier — triggers a hyper-cycle-peak sell-the-news despite a clean beat.
The market's narrative
Street expects another 20%+ EPS beat on HBM ramp + DRAM ASP inflection, with Q1 FY27 guide anchoring the AI-memory super-cycle thesis into the year-end tape.
Where the Street may be wrong
- The 15% pullback from $1,255 ATH into $1,065 IS the pre-print de-risk — RSI 59 (not overbought), short float 2.45% (no squeeze fuel either), which flips the setup from priced-to-perfection to modestly de-risked and asymmetric to the upside if HBM4 qualification with NVDA gets called out on the print.
- Forward P/E 6.66x prices in Q1 FY27 EPS ~$40 as the whisper — any guide within 5% of that clears the bar, and an above-whisper guide (>$42) triggers a fresh leg up given how light options positioning is.
Peer read: NVDA and AVGO have both digested strong AI-infra prints without giving back gains, and SK Hynix HBM-price commentary through Sept has been supportive — no negative peer-read overhang into this print.
Reasoning
- AI-INFRA-MEGA-CAP-TAPE-REJECTS-BEATS regime rule is in play but partially offset: MU spot -15% from ATH into the print materially reduces the priced-to-perfection risk (rule requires spot within 5% of 52wk high AND stretched positioning; MU fails the first condition).
- EPS trajectory is parabolic — $3.03 → $4.78 → $12.20 → $25.11 → my $33.50 estimate — driven by HBM3E/HBM4 ASP + DRAM tightness; my $33.50 sits +5.3% above $31.82 consensus, tracking the +20% beat cadence of the last two quarters.
- Positioning is neutral-to-supportive: rating skew 30 Buy / 4 Hold / 0 Sell, PT $1,580 = ~48% upside, short float 2.45% + 0.8 days-to-cover means no forced covers but also no aggressive short leverage betting against.
- Guide is the fulcrum, not the headline: fwd P/E 6.66x implies whisper Q1 FY27 EPS ~$40; my base case is an in-line-to-modestly-above guide (~$41-$43), catalyzing a +2-4% pop; risk case is a conservative guide anchored at $37-$38 which would trigger a hyper-cycle-peak sell-the-news.
- Options skew light, RSI 59.7 non-extended, IV crush expected but the +/- 6% straddle suggests directional resolution priced — asymmetric UP given three of four possible print/guide combos are net-positive.
Risks to the call
- Q1 FY27 guide anchored at $37-$38 EPS (in-line with older street, well below the 6.66x fwd-P/E-implied whisper of $40+) triggers a hyper-cycle-peak sell-the-news despite a clean beat — this is the classic AI-INFRA-MEGA-CAP-TAPE-REJECTS-BEATS trap.
- DRAM/NAND ASP commentary flagging a Q1 FY27 sequential deceleration (even one qualifier like 'moderating price gains') would collapse the AI-memory super-cycle narrative and drag the stock -8-12% regardless of headline.